SCHEMBL9425652

SCHEMBL9425652

CCCCCC(C[C]=O)CCCCC

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
GPR84 Q9NQS5 7/20 0.41
FFAR1 O14842 2/20 0.41
MAPT P10636 2/20 0.40
OPRM1 P35372 1/20 0.39
FDPS P14324 4/20 0.38
FFAR4 Q5NUL3 1/20 0.38
TRPA1 O75762 1/20 0.38
DDAH1 O94760 1/20 0.38
GAPDH P04406 1/20 0.38
SPHK1 Q9NYA1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16196233 0.98 LMNA (0.50) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL27538738 0.98 LMNA (0.50) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL5274110 0.95 LMNA (0.43) LMNAGPR84FFAR1MAPTOPRM1
SCHEMBL9263682 0.93 LMNA (0.46) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL8705110 0.93 LMNA (0.46) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL444298 0.91 ALDH1A1 (0.43) LMNAGPR84FFAR1MAPTOPRM1
SCHEMBL9262114 0.89 LMNA (0.46) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL8459302 0.89 LMNA (0.46) LMNAGPR84FFAR1MAPTFDPS
SCHEMBL6464272 0.86 FAAH (0.48) LMNAFFAR1MAPTFFAR4
SCHEMBL10580211 0.85 ALDH1A1 (0.43) LMNAGPR84FFAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed